PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 240.00
-4.00 (-1.64%)
Sep 2, 2026, 3:04 PM WIB
IDX:DGNS Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,044 | 2,937 | 747.44 | -13,656 | 12,665 | 64,304 |
Depreciation & Amortization | 10,123 | 11,011 | 14,612 | 14,634 | 13,310 | 7,562 |
Other Amortization | 308.69 | 308.69 | 271.39 | - | - | - |
Other Operating Activities | -3,805 | -3,598 | 11,668 | 12,205 | -31,931 | -12,990 |
Operating Cash Flow | 8,671 | 10,658 | 27,299 | 13,184 | -5,956 | 58,875 |
Operating Cash Flow Growth | -48.77% | -60.96% | 107.07% | - | - | 124.47% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -4,476 | -8,073 | -43,394 | -38,324 | -34,096 | -67,841 |
Sale of Property, Plant & Equipment | - | 110.72 | 117.12 | 649.65 | - | - |
Sale (Purchase) of Intangibles | -1,775 | -625.82 | -904.18 | -208 | -756.8 | - |
Investment in Securities | -15,149 | - | - | -4,506 | -8,051 | -6,507 |
Other Investing Activities | - | - | - | - | 25,354 | -1,219 |
Investing Cash Flow | -21,400 | -8,588 | -44,181 | -42,389 | -17,550 | -75,568 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 5,000 | 15,000 | 38,978 | 11,606 | - |
Long-Term Debt Repaid | - | -2,373 | -2,744 | -23,728 | -4,749 | -4,900 |
Net Debt Issued (Repaid) | 27,066 | 2,627 | 12,256 | 15,250 | 6,857 | -4,900 |
Issuance of Common Stock | - | - | - | - | - | 49,478 |
Common Dividends Paid | - | - | - | - | - | -6,000 |
Other Financing Activities | -1,087 | -431.03 | -1,409 | -3,810 | - | 6,296 |
Financing Cash Flow | 25,979 | 2,196 | 10,846 | 11,439 | 6,857 | 44,874 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -60 | - |
Net Cash Flow | 13,250 | 4,266 | -6,036 | -17,766 | -16,709 | 28,182 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4,195 | 2,585 | -16,095 | -25,141 | -40,052 | -8,966 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 2.38% | 1.55% | -9.87% | -17.26% | -20.77% | -2.97% |
Free Cash Flow Per Share | 3.20 | 2.07 | -12.88 | -20.11 | -32.04 | -7.23 |
Levered Free Cash Flow | -5,443 | 2,308 | -20,631 | -17,955 | -13,691 | -29,353 |
Unlevered Free Cash Flow | -4,723 | 2,793 | -20,080 | -17,658 | -13,298 | -29,146 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 3,841 | 3,739 | 2,614 | 475.24 | 772 | - |
Cash Income Tax Paid | 20.33 | - | - | 10.08 | 20,082 | 16,185 |